Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine

Abstract Background The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory c...

Full description

Bibliographic Details
Main Authors: Alain Aguirre-Vázquez, Fabiola Castorena-Torres, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, María Elena Camacho-Moll, Luis A. Salazar-Olivo, Iván Velasco, Mario Bermúdez de León
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-023-03268-w
_version_ 1797865387281350656
author Alain Aguirre-Vázquez
Fabiola Castorena-Torres
Beatriz Silva-Ramírez
Katia Peñuelas-Urquides
María Elena Camacho-Moll
Luis A. Salazar-Olivo
Iván Velasco
Mario Bermúdez de León
author_facet Alain Aguirre-Vázquez
Fabiola Castorena-Torres
Beatriz Silva-Ramírez
Katia Peñuelas-Urquides
María Elena Camacho-Moll
Luis A. Salazar-Olivo
Iván Velasco
Mario Bermúdez de León
author_sort Alain Aguirre-Vázquez
collection DOAJ
description Abstract Background The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory constitutes an obstacle in cellular reprogramming. Here, we report the effect of hydralazine (HYD) and valproic acid (VPA), two small molecules with proven epigenetic activity, on the expression of pluripotency genes in adult (aHF) and neonatal (nbHF) human fibroblasts. Methods aHF and nbHF were treated with HYD and/or VPA, and viability and gene expression assays for OCT4, NANOG, c-MYC, KLF4, DNMT1, TET3, ARID1A and ARID2 by quantitative PCR were performed. aHF and nbHF were transfected with episomal plasmid bearing Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) and exposed to HYD and VPA to determine the reprogramming efficiency. Methylation sensitive restriction enzyme (MSRE) qPCR assays were performed on OCT4 and NANOG promoter regions. Immunofluorescence assays were carried out for pluripotency genes on iPSC derived from aHF and nbHF. Results HYD upregulated the expression of OCT4 (2.5-fold) and NANOG (fourfold) genes but not c-Myc or KLF4 in aHF and had no significant effect on the expression of all these genes in nbHF. VPA upregulated the expression of NANOG (twofold) in aHF and c-MYC in nbHF, while it downregulated the expression of NANOG in nbHF. The combination of HYD and VPA canceled the OCT4 and NANOG overexpression induced by HYD in aHF, while it reinforced the effects of VPA on c-Myc expression in nbHF. The HYD-induced overexpression of OCT4 and NANOG in aHDF was not dependent on demethylation of gene promoters, and no changes in the reprogramming efficiency were observed in both cell populations despite the downregulation of epigenetic genes DNMT1, ARID1A, and ARID2 in nbHF. Conclusions Our data provide evidence that HYD regulates the expression of OCT4 and NANOG pluripotency genes as well as ARID1A and ARID2 genes, two members of the SWI/SNF chromatin remodeling complex family, in normal human dermal fibroblasts.
first_indexed 2024-04-09T23:07:12Z
format Article
id doaj.art-36bc57491bfd4636beab815676ce8da9
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-04-09T23:07:12Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-36bc57491bfd4636beab815676ce8da92023-03-22T10:34:53ZengBMCStem Cell Research & Therapy1757-65122023-03-0114111410.1186/s13287-023-03268-wCell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazineAlain Aguirre-Vázquez0Fabiola Castorena-Torres1Beatriz Silva-Ramírez2Katia Peñuelas-Urquides3María Elena Camacho-Moll4Luis A. Salazar-Olivo5Iván Velasco6Mario Bermúdez de León7Departamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro SocialEscuela de Medicina, Tecnologico de MonterreyDepartamento de Inmunogenética, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro SocialDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro SocialDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro SocialDepto. de Biología Molecular, Instituto Potosino de Investigación Científica y TecnológicaInstituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de MéxicoDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro SocialAbstract Background The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory constitutes an obstacle in cellular reprogramming. Here, we report the effect of hydralazine (HYD) and valproic acid (VPA), two small molecules with proven epigenetic activity, on the expression of pluripotency genes in adult (aHF) and neonatal (nbHF) human fibroblasts. Methods aHF and nbHF were treated with HYD and/or VPA, and viability and gene expression assays for OCT4, NANOG, c-MYC, KLF4, DNMT1, TET3, ARID1A and ARID2 by quantitative PCR were performed. aHF and nbHF were transfected with episomal plasmid bearing Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) and exposed to HYD and VPA to determine the reprogramming efficiency. Methylation sensitive restriction enzyme (MSRE) qPCR assays were performed on OCT4 and NANOG promoter regions. Immunofluorescence assays were carried out for pluripotency genes on iPSC derived from aHF and nbHF. Results HYD upregulated the expression of OCT4 (2.5-fold) and NANOG (fourfold) genes but not c-Myc or KLF4 in aHF and had no significant effect on the expression of all these genes in nbHF. VPA upregulated the expression of NANOG (twofold) in aHF and c-MYC in nbHF, while it downregulated the expression of NANOG in nbHF. The combination of HYD and VPA canceled the OCT4 and NANOG overexpression induced by HYD in aHF, while it reinforced the effects of VPA on c-Myc expression in nbHF. The HYD-induced overexpression of OCT4 and NANOG in aHDF was not dependent on demethylation of gene promoters, and no changes in the reprogramming efficiency were observed in both cell populations despite the downregulation of epigenetic genes DNMT1, ARID1A, and ARID2 in nbHF. Conclusions Our data provide evidence that HYD regulates the expression of OCT4 and NANOG pluripotency genes as well as ARID1A and ARID2 genes, two members of the SWI/SNF chromatin remodeling complex family, in normal human dermal fibroblasts.https://doi.org/10.1186/s13287-023-03268-wHydralazineValproic acidiPSCFibroblastsReprogrammingGenes
spellingShingle Alain Aguirre-Vázquez
Fabiola Castorena-Torres
Beatriz Silva-Ramírez
Katia Peñuelas-Urquides
María Elena Camacho-Moll
Luis A. Salazar-Olivo
Iván Velasco
Mario Bermúdez de León
Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
Stem Cell Research & Therapy
Hydralazine
Valproic acid
iPSC
Fibroblasts
Reprogramming
Genes
title Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
title_full Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
title_fullStr Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
title_full_unstemmed Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
title_short Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
title_sort cell type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine
topic Hydralazine
Valproic acid
iPSC
Fibroblasts
Reprogramming
Genes
url https://doi.org/10.1186/s13287-023-03268-w
work_keys_str_mv AT alainaguirrevazquez celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT fabiolacastorenatorres celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT beatrizsilvaramirez celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT katiapenuelasurquides celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT mariaelenacamachomoll celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT luisasalazarolivo celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT ivanvelasco celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine
AT mariobermudezdeleon celltypedependentregulationofpluripotencyandchromatinremodelinggenesbyhydralazine